Free Trial
→ Market Panic: Trump Just Dropped a Bomb on Your Stocks (From American Alternative) (Ad)tc pixel Free RNAC Stock Alerts

Cartesian Therapeutics (RNAC) Institutional Ownership

Cartesian Therapeutics logo
$9.96 -0.09 (-0.85%)
As of 01:18 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Cartesian Therapeutics (NASDAQ:RNAC)

Current
Institutional Ownership
Percentage
86.95%
Number of
Institutional Buyers
(last 12 months)
31
Total
Institutional Inflows
(last 12 months)
$52.41M
Number of
Institutional Sellers
(last 12 months)
14
Total
Institutional Outflows
(last 12 months)
$54.05M
Get RNAC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cartesian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

RNAC Institutional Buying and Selling by Quarter

Cartesian Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025 Bank of America Corp DE13,933$145K0.0%+133.0%0.054%
8/15/2025 683 Capital Management LLC219,000$2.28M0.1%+46.0%0.842%
8/14/2025 MPM Bioimpact LLC686,007$7.13M1.2%-13.2%2.638%
8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,056$53K0.0%-16.0%0.019%
8/13/2025 Marshall Wace LLP82,630$859K0.0%+114.0%0.318%
8/13/2025 Virtus Investment Advisers LLC9,183$95K0.0%+12.5%0.035%
8/12/2025 JPMorgan Chase & Co.6,080$63K0.0%-96.9%0.023%
8/12/2025 Miller Financial Services LLC11,643$121K0.2%N/A0.045%
8/8/2025 Geode Capital Management LLC218,927$2.28M0.0%-2.9%0.844%
7/31/2025 AlphaQuest LLC4,207$44K0.0%-41.5%0.016%
6/27/2025 Goldman Sachs Group Inc.15,775$208K0.0%-42.7%0.061%
5/29/2025Rhumbline Advisers13,006$171K0.0%+27.5%0.050%
5/23/2025Siren L.L.C.563,272$7.42M0.4%-1.6%2.170%
5/16/2025Goldman Sachs Group Inc.15,775$208K0.0%-42.7%0.061%
5/16/2025683 Capital Management LLC150,000$1.98M0.1%+20.0%0.578%
5/15/2025MPM Bioimpact LLC790,779$10.42M1.8%+9.7%3.049%
5/15/2025Siren L.L.C.563,272$7.42M0.4%-1.6%2.172%
5/14/2025AlphaQuest LLC7,191$95K0.0%N/A0.028%
5/14/2025Erste Asset Management GmbH260,011$3.43M0.0%+49.8%1.002%
5/13/2025Twin Focus Capital Partners LLC15,000$198K0.0%+25.0%0.058%
5/12/2025Nuveen LLC27,869$367K0.0%N/A0.107%
5/9/2025Deutsche Bank AG7,424$98K0.0%+104.1%0.029%
5/9/2025Charles Schwab Investment Management Inc.29,303$386K0.0%+9.3%0.113%
4/30/2025Alps Advisors Inc.19,392$256K0.0%-5.6%0.075%
4/29/2025Bank of New York Mellon Corp20,937$276K0.0%+7.9%0.081%
4/8/2025Rhumbline Advisers13,006$171K0.0%+27.5%0.050%
2/17/2025Two Sigma Investments LP11,812$212K0.0%-8.5%0.046%
2/17/2025MPM Bioimpact LLC721,139$12.92M1.8%+14.6%2.837%
2/17/2025Nuveen Asset Management LLC72,099$1.29M0.0%+197.8%0.284%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.5,786$104K0.0%+44.8%0.023%
2/17/2025Citadel Advisors LLC315,000$5.64M0.0%-16.2%1.239%
2/17/2025Bank of America Corp DE11,690$209K0.0%+54.4%0.046%
2/17/2025683 Capital Management LLC125,000$2.24M0.1%+65.7%0.492%
2/14/2025Northern Trust Corp95,030$1.70M0.0%+50.6%0.374%
2/14/2025Virtus ETF Advisers LLC3,533$63K0.0%N/A0.014%
2/14/2025MetLife Investment Management LLC6,667$119K0.0%N/A0.026%
2/13/2025Barclays PLC19,099$342K0.0%+64.5%0.075%
2/13/2025Renaissance Technologies LLC13,800$247K0.0%N/A0.054%
2/13/2025Wells Fargo & Company MN4,847$87K0.0%+112.7%0.019%
2/12/2025Geode Capital Management LLC221,257$3.96M0.0%+63.0%0.870%
2/12/2025JPMorgan Chase & Co.274,740$4.92M0.0%-11.1%1.081%
2/11/2025Corebridge Financial Inc.5,122$92K0.0%+32.6%0.020%
2/10/2025Erste Asset Management GmbH173,566$3.26M0.0%-93.6%0.683%
2/6/2025Charles Schwab Investment Management Inc.26,803$480K0.0%+40.7%0.105%
2/4/2025Bank of New York Mellon Corp19,407$348K0.0%+28.5%0.076%
1/31/2025New York State Common Retirement Fund3,902$70K0.0%-23.5%0.015%
1/30/2025Rhumbline Advisers10,201$183K0.0%+10.0%0.040%
1/27/2025Mirae Asset Global Investments Co. Ltd.4,562$82K0.0%+22.8%0.018%
1/24/2025China Universal Asset Management Co. Ltd.5,389$97K0.0%N/A0.021%
12/26/2024JPMorgan Chase & Co.309,018$4.98M0.0%+0.9%1.216%
11/19/2024Barclays PLC11,611$188K0.0%+208.6%0.046%
11/16/2024Geode Capital Management LLC135,700$2.19M0.0%+2.1%0.534%
11/15/2024Barclays PLC11,611$188K0.0%+208.6%0.046%
11/15/2024State Street Corp157,495$2.54M0.0%+2.5%0.620%
11/15/2024Ikarian Capital LLC52,193$841K0.1%-78.5%0.205%
11/13/2024Great Point Partners LLC200,000$3.22M0.9%N/A0.787%
11/13/2024BNP Paribas Financial Markets1,651$27K0.0%+122.5%0.006%
11/13/2024FMR LLC2,851,830$45.97M0.0%+458.3%11.219%
10/23/2024Lake Street Advisors Group LLC15,822$255K0.0%-50.0%0.074%
9/16/2024Point72 DIFC Ltd1,725$47K0.0%N/A0.008%
9/16/2024Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061%
9/16/2024Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009%
8/27/2024Logos Global Management LP90,000$2.43M0.2%N/A0.506%
8/15/2024Point72 Asia Singapore Pte. Ltd.1,824$49K0.0%N/A0.009%
8/14/2024Cubist Systematic Strategies LLC13,010$351K0.0%N/A0.061%
8/14/2024Point72 DIFC Ltd1,725$47K0.0%N/A0.008%
8/14/2024Marshall Wace LLP30,038$811K0.0%N/A0.140%
8/14/2024Logos Global Management LP90,000$2.43M0.2%N/A0.421%
8/9/2024Renaissance Technologies LLC17,052$461K0.0%-96.9%0.096%
8/6/2024Lake Street Advisors Group LLC31,644$855K0.0%N/A0.178%
8/1/2024Rhumbline Advisers8,487$229K0.0%-93.5%0.048%
7/26/2024Bank of New York Mellon Corp19,916$538K0.0%-93.7%0.112%
7/22/2024Hall Laurie J Trustee1,759$48K0.0%-96.7%0.010%
5/17/2024Artal Group S.A.9,136,635$5.94M0.2%N/A171.098%
5/14/2024American International Group Inc.56,202$37K0.0%N/A1.052%
5/10/2024Vanguard Group Inc.6,315,113$4.11M0.0%N/A118.172%
5/7/2024SG Americas Securities LLC47,134$31K0.0%N/A0.883%
5/3/2024Delphi Financial Group Inc.660,852$430K0.3%N/A12.261%
5/1/2024BNP Paribas Financial Markets59,125$38K0.0%N/A1.097%
4/23/2024Hall Laurie J Trustee52,775$34K0.0%N/A0.979%
(Data available from 1/1/2016 forward)

RNAC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of RNAC shares?

During the previous two years, 49 institutional investors and hedge funds held shares of Cartesian Therapeutics. The most heavily invested institutionals were FMR LLC ($45.97M), Siren L.L.C. ($7.42M), MPM Bioimpact LLC ($7.13M), Artal Group S.A. ($5.94M), Citadel Advisors LLC ($5.64M), Vanguard Group Inc. ($4.11M), and Erste Asset Management GmbH ($3.43M).Learn more on Cartesian Therapeutics' institutional investors.

What percentage of Cartesian Therapeutics' stock is owned by institutional investors?

86.95% of Cartesian Therapeutics' stock is owned by institutional investors. Learn more on RNAC's institutional investor holdings.

Which institutional investors have been buying Cartesian Therapeutics' stock?

Of the 42 institutional investors that purchased Cartesian Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Artal Group S.A. ($9.14M), Vanguard Group Inc. ($6.32M), FMR LLC ($2.34M), Delphi Financial Group Inc. ($660.85K), Great Point Partners LLC ($200K), Logos Global Management LP ($180K), and MPM Bioimpact LLC ($161.36K).

How much institutional buying is happening at Cartesian Therapeutics?

Institutional investors have bought a total of 3,300,222 shares in the last 24 months. This purchase volume represents approximately $52.41M in transactions.

Which of Cartesian Therapeutics' major shareholders have been selling company stock?

Of the 14 institutional investors that sold Cartesian Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Erste Asset Management GmbH ($2.53M), JPMorgan Chase & Co. ($223.24K), Ikarian Capital LLC ($190.18K), MPM Bioimpact LLC ($104.77K), Citadel Advisors LLC ($60.77K), Goldman Sachs Group Inc. ($23.50K), and Siren L.L.C. ($17.93K).

How much institutional selling is happening at Cartesian Therapeutics?

Institutional investors have sold a total of 3,177,179 shares in the last 24 months. This volume of shares sold represents approximately $54.05M in transactions.


Related Companies

This page (NASDAQ:RNAC) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
Refund From 1933: Trump’s Reset May Create Instant Wealth
Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...
American Hartford Gold | Sponsoredtc pixel
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...
Paradigm Press | Sponsoredtc pixel
Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...
SmartAsset | Sponsoredtc pixel
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...
Investors Alley | Sponsoredtc pixel